PTH134

DRUG2 trials

Sponsors

Novartis

Conditions

Post-menopausal OsteoporosisPostmenopausal Osteoporosis

Phase 1

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects

CompletedNCT00676312

NovartisPostmenopausal Osteoporosis

Start: 2008-05-31Target: 32Updated: 2008-12-11

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Doses of PTH134 in Post-menopausal Women

CompletedNCT01224717

NovartisPost-menopausal Osteoporosis

Start: 2010-09-30Updated: 2011-05-13